Monday, May 16, 2022 8:34:47 AM
August 26th 2019 company files a DEF-14c to approve the option for a possible RS from 100 to 1 to 1000 to 1 The stock closed on the trading day before at 0.001 cents.
The possibly of that RS remained active from August 26th 2019 to February 17, 2021, the day before the RS was canceled , February 16th 2021 the stock closed at 13.8 cents.
So from August 26 2019 to February 16, 2021 while the possibility of a 1000 to 1 RS hung over the company head the stock appreciated from a low of 0.001 to a high of 34.9 cents and a close of 13.8 the day before cancelling.
From February 17, 2021 to April 11, 2022 the stock was tradeing WITH NO RS OPTION in place.
On February 17, 2021 the stock opened at 13.8 cents on April 11, 2022 the stock closed at 0.008.
So with NO RS OPTION in place the stock depreciated from 13.8 cents to 0.008 cents.
April 12. 2022 the Option for a RS split was put back on the books..
Between April 12,2022 to May 12, 2022 with the RS OPTION back in place, the stock price has remained the same..
Conclusion the stock has appreciated under a possible RS (0.001 to 13.8 cents with a high of 34.9 cents) while it has greatly depreciated when no RS option was in place (13.8 cents to 0.008 cents).
Maybe the shareholders should be worried if the company cancels it again.
Recent SNPW News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2024 09:04:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:15:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:30:36 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 10/23/2023 09:15:31 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 10/13/2023 09:00:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:06:10 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM